Patients May Benefit from Molecular Profiling of Tumor BRAF, PI3K, etc, would benefit from available drugs
Santosh Kesari, MD, explains Patients May Benefit from Molecular Profiling of Tumor BRAF, PI3K, etc, would benefit from available drugs at the 2018 Oncology Summit in Huntington Beach, CA <br /><br />Go to: ...
Author: moasc
Added: 03/15/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | Huntington's Disease